-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
Luminex Cytokine Detection Platform by InnoModels Biotechnology
Author:
InnoModels
Release time:
2024-07-18
As biomedical research continues to deepen, the demand for cytokines and other biomarkers is increasing. With its excellent R&D strength and profound technical accumulation, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the Luminex cytokine assay platform, which, with its unique technological features and significant advantages, has demonstrated strong application potential and value in biomedical research.
Highly sensitive multi-parameter detection capability:
Luminex cytokine detection platform adopts advanced xMAP technology, which couples highly specific capture monoclonal antibodies to different fluorescent labeled magnetic beads to achieve simultaneous detection of multiple cytokines. This technology not only improves the sensitivity of the assay, but also greatly reduces the experiment time and meets the demand for high-throughput, multi-indicator assays. The platform is capable of detecting a variety of molecules including cytokines, growth factors, cancer markers and other molecules, providing comprehensive data support for researchers.
Personalized assay chip customization:
The Luminex cytokine detection platform is highly flexible and customizable. According to the specific needs of researchers, personalized test chips can be customized to achieve accurate detection of specific cytokines. This customized service not only meets the individual needs of researchers, but also saves experimental costs and improves research efficiency.

Double Antibody Sandwich & Fluorescence Assay:
Luminex cytokine assay platform adopts double antibody sandwich & fluorescence assay, which effectively improves the accuracy and reliability of the assay. The technology utilizes a gradient dilution of the standard detection signal to construct a standard curve, realizing the simultaneous detection and accurate quantification of multiple factors in the target sample. In addition, the platform also has a low lower limit of detection, capable of detecting cytokines at the pg/mL level to meet the needs of micro-indicator detection.
Wide sample applicability:
The Luminex cytokine platform is suitable for a wide range of biological sample types, including serum/plasma, culture supernatants and cells, tissue lysates, etc. This makes the platform suitable for a wide range of biological samples. This wide range of sample applicability allows the platform to be used in a wide range of biomedical research applications and meets the needs of different fields of research.
Avoid batch-to-batch experimental errors:
Traditional cytokine assays often suffer from batch-to-batch experimental errors, affecting the reliability of the results. Luminex cytokine detection platform adopts highly specific antibody and fluorescent labeling technology, which effectively avoids batch-to-batch experimental errors and improves the accuracy and reliability of experimental results.
Simple operation and short cycle time:
Luminex cytokine detection platform is characterized by easy operation and short experimental cycle. The researcher only needs to add the samples to be tested into the specific reagent kit, and then automate the operation on the platform to complete the test. This simple operation process and fast experimental cycle make the platform more practical and convenient in biomedical research.
In conclusion, the Luminex cytokine assay platform of InnoModels Biotechnology has shown great potential and value in biomedical research due to its highly sensitive multi-parameter detection capability, customized assay chips, double anticoagulation & fluorescence assay, wide sample applicability, avoidance of inter-batch experimental errors, and easy operation and short experimental cycle. In the future, the platform will be applied and promoted in more fields, bringing more convenience and safety guarantee to people's health and life.
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd